Cargando…
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Oncogene-induced senescence acts as a barrier against tumour formation and has been implicated as the mechanism preventing the transformation of benign melanocytic lesions that frequently harbour oncogenic B-RAF or N-RAS mutations. In the present study we systematically assessed the relative importa...
Autores principales: | Haferkamp, Sebastian, Tran, Sieu L, Becker, Therese M, Scurr, Lyndee L, Kefford, Richard F, Rizos, Helen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806033/ https://www.ncbi.nlm.nih.gov/pubmed/20157537 |
Ejemplares similares
-
p16(INK4a)-induced senescence is disabled by melanoma-associated mutations
por: Haferkamp, Sebastian, et al.
Publicado: (2008) -
Antitumor mechanisms when pRb and p53 are genetically inactivated
por: Zhu, Liang, et al.
Publicado: (2014) -
Treating cancer when pRb and p53 cannot be reactivated
por: Zhu, Liang
Publicado: (2015) -
An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence
por: Rovillain, Emilie, et al.
Publicado: (2011) -
p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma
por: Supsavhad, Wachiraphan, et al.
Publicado: (2016)